Ontrak (NASDAQ: OTRK) is one of 27 publicly-traded companies in the “Miscellaneous health & allied services, not elsewhere classified” industry, but how does it weigh in compared to its rivals? We will compare Ontrak to similar businesses based on the strength of its valuation, dividends, risk, profitability, analyst recommendations, institutional ownership and earnings.
This table compares Ontrak and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Ontrak has a beta of 2.34, suggesting that its stock price is 134% more volatile than the S&P 500. Comparatively, Ontrak’s rivals have a beta of 7.07, suggesting that their average stock price is 607% more volatile than the S&P 500.
Institutional & Insider Ownership
33.0% of Ontrak shares are held by institutional investors. Comparatively, 43.2% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are held by institutional investors. 58.2% of Ontrak shares are held by company insiders. Comparatively, 26.4% of shares of all “Miscellaneous health & allied services, not elsewhere classified” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Valuation & Earnings
This table compares Ontrak and its rivals top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Ontrak||$82.84 million||-$22.71 million||-24.84|
|Ontrak Competitors||$1.94 billion||$96.17 million||42.17|
Ontrak’s rivals have higher revenue and earnings than Ontrak. Ontrak is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This is a summary of current ratings and target prices for Ontrak and its rivals, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Ontrak presently has a consensus target price of $42.60, suggesting a potential upside of 32.96%. As a group, “Miscellaneous health & allied services, not elsewhere classified” companies have a potential upside of 7.27%. Given Ontrak’s stronger consensus rating and higher possible upside, analysts clearly believe Ontrak is more favorable than its rivals.
Ontrak rivals beat Ontrak on 8 of the 13 factors compared.
Ontrak Company Profile
Ontrak, Inc. operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors. Its Ontrak PRE (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren't getting the care they need. The company's technology-enabled, OnTrak, program is designed to treat health plan members with unaddressed behavioral health conditions that cause or exacerbate chronic medical diseases, such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was founded in 2003 and is headquartered in Santa Monica, California.
Receive News & Ratings for Ontrak Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ontrak and related companies with MarketBeat.com's FREE daily email newsletter.